<SEC-DOCUMENT>0000921895-23-000056-index.html : 20230105 <SEC-HEADER>0000921895-23-000056.hdr.sgml : 20230105 <ACCEPTANCE-DATETIME>20230105143813 ACCESSION NUMBER: 0000921895-23-000056 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87951 FILM NUMBER: 23510790 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Radoff Bradley Louis CENTRAL INDEX KEY: 0001380585 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 2727 KIRBY DRIVE STREET 2: UNIT 29L CITY: HOUSTON STATE: TX ZIP: 77098 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D/A <SEQUENCE>1 <FILENAME>sc13da209076053_01052023.htm <DESCRIPTION>AMENDMENT NO. 2 TO THE SCHEDULE 13D <TEXT> Document 1 - file: sc13da209076053_01052023.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex991to13da209076053_010523.htm <DESCRIPTION>PRESS RELEASE <TEXT> Document 2 - file: ex991to13da209076053_010523.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ex992to13da209076053_010523.htm <DESCRIPTION>OPEN LETTER <TEXT> Document 3 - file: ex992to13da209076053_010523.htm
</DOCUMENT> </SEC-DOCUMENT>